# Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-of-polycystic-kidney-disease-with-a-novel-tyrosine-kinase-inhibitor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | William E. Sweeney,Yue-Gang Chen,Koichi Nakanishi,Philip Frost,Ellis D. Avner |
| Citations | 219 |
| DOI | 10.1046/j.1523-1755.2000.00829.x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.kidney-international.org/article/S0085253815467031/pdf |
| OpenAlex ID | https://openalex.org/W1966120295 |
| PMID | 10620185 |
| Type | article |
| Year | 2000 |

## Paper authors

- [Koichi Nakanishi](https://scholariq.org/researchers/koichi-nakanishi/)

## Paper journal

- [Kidney International](https://scholariq.org/journals/kidney-international/)

## Paper primary topic

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)

## Paper topics

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)
- [Biomedical Research and Pathophysiology](https://scholariq.org/topics/biomedical-research-and-pathophysiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.